CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Medtronic Hybrid Closed-loop System - Android Platform +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02280863
NCT02280863N/ACompleted
CompareCT.gov

Hybrid Closed-Loop Studies With Medtronic PID Controller- Hotel HCL Study

Stanford University·interventional·Posted Nov 3, 2014·Updated Jul 3, 2018

In Brief

A clinical study evaluating Medtronic Hybrid Closed-loop System - Android Platform and Medtronic Hybrid Closed-loop Integrated System for Type 1 Diabetes. Completed, enrolled 24 participants across 3 sites.

Detailed Summary

The primary objective of this study is to evaluate the safety and efficacy of the Medtronic hybrid closed-loop (HCL) system utilizing the proportional-integral-derivative algorithm with insulin feedback (PID-IFB) optimized to function in a hybrid mode with closed-loop control operating during the day and night.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedNov 3, 2014
Enrollment StartJul 1, 2014
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 11.7 years ago

Interventions

Medtronic Hybrid Closed-loop System - Android Platformdevice

A continuous glucose sensor and insulin delivery system designed for continuous closed-loop control with the PID-IFB (proportional-integral-derivative insulin feed-back) algorithm using an Android controller.

Medtronic Hybrid Closed-loop Integrated Systemdevice

A fully integrated continuous glucose sensor and insulin delivery system designed for continuous closed-loop control with the PID-IFB (proportional-integral-derivative insulin feed-back) algorithm